BSEBoard Meeting8 Oct 2026 · 8 Oct 2026, 04:23 pm

Dharti Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/10/2026 ,inter alia, to consider and approve 1. The Audited Standalone Financial Results of the Company for the second quarter and half year ended 30th September, 2026 and to take on record the Interim Audit Report thereon; & 2. The proposal for issue of bonus shares to the public shareholders of the Company in order to achieve compliance ....

Dharti Proteins Ltd · 531171

✦ AI SummaryResults

Dharti Proteins Ltd has scheduled a board meeting on 13th October 2026 to consider and approve its audited standalone financial results for the second quarter and half year ended 30th September 2026, and to consider the proposal for issue of bonus shares to public shareholders to achieve compliance with minimum public shareholding requirements.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk3/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Dharti Proteins Ltd - 531171 - Board Meeting Intimation for Meeting Of Board Of Directors To Be Held On Tuesday, 13Th October, 2026

Attachments (1)

📄

92c6bacf-a387-4461-b9c3-cb87c9a68b72.pdf

pdf

Download →
View document text
08th October, 2026 The General Manager, Listing Department, BSE Limited Pheeroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001, Maharashtra India Symbol: DHARTI ISIN: INE248C01021 Scrip Code: 531171 Dear Sir/Madam, Subject: Intimation of Fourth Board Meeting of FY 2026-2027 of the Board of Directors of the Company scheduled to be held on Tuesday, 13th October, 2026. Ref: Disclosure under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, as amended from time to time, we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 13th October, 2026 to discuss the following:  To consider, discuss and approve the Audited Standalone Financial Results of the Company for the second quarter and half year ended 30th September, 2026 and to take on record the Interim Audit Report thereon.  To consider the proposal for issue of bonus shares to the public shareholders of the Company in order to achieve compliance with the Minimum Public Shareholding requirements mandated under rule 19A of the Securities Contracts (Regulation) Rules, 1957 read with regulation 38 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations, 2015.  To consider any other matter with the permission of the chair. You are requested to take the same on your record. Yours Faithfully, For DHARTI PROTEINS LIMITED Twinkle Bipinchandra Gajjar Company Secretary and Compliance Officer ICSI Membership No. A77101